Hefen Yu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research
Papers in
-
- RNA modifications and cancer 13
- Cancer-related gene regulation 8
- RNA Research and Splicing 7
- Epigenetics and DNA Methylation 7
- Wnt/β-catenin signaling in development and cancer 3
-
- Cancer-related molecular mechanisms research 7
- Co-authors
- Xu Teng (20 shared papers)Wen G. Jiang (13 shared papers)Tianshu Yang (11 shared papers)Yan Wang (13 shared papers)Wei Huang (13 shared papers)Huishan Zhao (6 shared papers)Si Yang (5 shared papers)Xin Yin (9 shared papers)
- Journals
- Frontiers in Oncology (5 papers)International Journal of Oncology (3 papers)Oncotarget (2 papers)Oncology Reports (2 papers)Cell Death and Differentiation (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Hefen Yu
43 papers receiving 726 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 191
- Molecular Biology 486
- Oncology 133
- Pulmonary and Respiratory Medicine 114
- Immunology and Allergy 18
Countries citing papers authored by Hefen Yu
This map shows the geographic impact of Hefen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hefen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hefen Yu more than expected).
Fields of papers citing papers by Hefen Yu
This network shows the impact of papers produced by Hefen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hefen Yu. The network helps show where Hefen Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hefen Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 61 | |
| 2 | 2017 | 57 | |
| 3 | 2018 | 50 | |
| 4 | 2014 | 47 | |
| 5 | 2021 | 46 | |
| 6 | 2022 | 45 | |
| 7 | 2020 | 31 | |
| 8 | 2019 | 28 | |
| 9 | 2010 | 28 | |
| 10 | 2020 | 27 | |
| 11 | 2016 | 25 | |
| 12 | 2019 | 21 | |
| 13 | 2023 | 17 | |
| 14 | The Clinical Implications of RSK1-3 in Human Breast Cancer. | 2016 | 17 |
| 15 | 2018 | 17 | |
| 16 | 2010 | 17 | |
| 17 | 2018 | 17 | |
| 18 | 2016 | 15 | |
| 19 | 2020 | 13 | |
| 20 | 2016 | 13 |
About Hefen Yu
Hefen Yu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Immunology and Allergy, having authored 44 papers that have together received 735 indexed citations. Recurring topics across this work include RNA modifications and cancer (13 papers), Cancer-related gene regulation (8 papers), RNA Research and Splicing (7 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related molecular mechanisms research (7 papers), Ferroptosis and cancer prognosis (6 papers), Cell Adhesion Molecules Research (5 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). The work is most often cited by research in Cancer Research (191 citations), Molecular Biology (486 citations), Oncology (133 citations), Pulmonary and Respiratory Medicine (114 citations) and Immunology and Allergy (18 citations). Hefen Yu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xu Teng, Wen G. Jiang, Tianshu Yang, Yan Wang, Wei Huang, Huishan Zhao, Si Yang, Xin Yin, Wei Liu and Jingyao Zhang. Their work appears in journals such as Frontiers in Oncology, International Journal of Oncology, Oncotarget, Oncology Reports and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.